The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study.
Qin P, Qin T, Liang L, Li X, Jiang B, Wang X, Ma J, Hu F, Zhang M, Hu D.
Cardiovasc Diabetol. 2024 Jan 28;23(1):45. doi: 10.1186/s12933-023-02074-1.
PMID:38282013
Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.
Yousri NA, Suhre K, Yassin E, Al-Shakaki A, Robay A, Elshafei M, Chidiac O, Hunt SC, Crystal RG, Fakhro KA.
Diabetes. 2022 Feb 1;71(2):184-205. doi: 10.2337/db21-0490.
PMID:34732537
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
Jung UJ, Choi MS.
Int J Mol Sci. 2014 Apr 11;15(4):6184-223. doi: 10.3390/ijms15046184.
PMID:24733068
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.
Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT.